Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,503.45
(
-1.56%
)
US TECH 100
23,272.00
(
-1.89%
)
Dow Jones
45,540.44
(
-1.05%
)
Brent Oil
108.46
(
3.85%
)
Bitcoin
69,879.53
(
-0.03%
)
News Focus
News Focus
Post# of 257262
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 843
Posts 122802
Boards Moderated 10
Alias Born 09/05/2002

DewDiligence

Member Level

Re: DewDiligence post# 130498

Monday, 01/30/2012 11:22:10 PM

Monday, January 30, 2012 11:22:10 PM

Post# of 257262
FDA approves LLY’s Jentadueto, a combination of Tradjenta and metformin:

http://finance.yahoo.com/news/FDA-approves-Jentadueto-prnews-2409356170.html?x=0

Tradjenta, which was approved by the FDA in May 2011 (#msg-62668535) and by the CHMP is Jun 2011 (#msg-64617999), is the drug from B-I that caused LLY to pull out of its partnership with AMLN following a period brief litigation (#msg-68775229, #msg-63176632).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Where Real Traders Talk Markets

Join thousands of traders sharing insights, catalysts, and charts.

Join Today